Janssen Research & Development

Innovation

Could Changes in Your Microbiome Increase Your Risk of Colorectal Cancer?

That's exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that's looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.

ON NOW

Personal Stories

4 Things COVID-19 Taught an ER Doctor About the Power of Resilience and Hope

At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.

ON NOW

Innovation

"I'm Racing to Screen Thousands of Molecules": These Scientists Are Canvassing a Vast Library in Search of a Potential COVID-19 Treatment

Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.

ON NOW

Innovation

Alzheimer’s Disease: Why One Company Refuses to Give Up the Search for a Cure

It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.

ON NOW

Innovation

Cracking the Genetic Code: Why Gene Sequencing May Hold the Key to Intercepting Diseases Before They Start

Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.

ON NOW

Esi Lamousé-Smith in the lab with colleagues reviewing microbial data

Innovation

Have IBD? Read About the Next Frontier in Disease Research That Taps Into the Microbiome

There are trillions of microorganisms living in your gut—and they might just be the key to helping treat diseases like Crohn's and ulcerative colitis. Meet a researcher who spends her days exploring this microscopic world.

ON NOW

Innovation

Clinical Trials 2.0: 5 Ways Johnson & Johnson Is Helping Revamp—and Revolutionize—How They're Conducted

From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.

ON NOW

Dr. Heather Davis with her colleagues in a research laboratory

Innovation

4 Questions for a Scientist Determined to Find a Functional Cure for Hepatitis B

Despite being one of the oldest viruses known to infect man, there's been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.

ON NOW

Doctors looking at a lung scan on a tablet

Latest News

Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions

Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company's fiscal future.

ON NOW

Health & Wellness

5 Things We Now Know About Prostate Cancer

For Men's Health Month, school yourself on the latest screenings and treatments for this most common male cancer.

ON NOW

Innovation

In Search of the Next Great Female Thinkers: Why Johnson & Johnson Is on a STEM2D Mission

The company just awarded six promising female researchers $150,000 each through its new Scholars Award program—and that's not the only way it's helping women working in the sciences.

ON NOW

Innovation

Ebola: The Fight Continues Four Years After the Worst Outbreak in History

Macaya Douoguih volunteered to lead an accelerated clinical program for a new investigational Ebola vaccine at the height of the 2014 epidemic in West Africa. She reflects on her experiences—and why her work must continue today.

Internet Explorer is no longer supported by this website.

Janssen Research & Development